May 16, 2018

Oncolytics Biotech® Announces Publication of REOLYSIN® Abstract for the ASCO 2018 Annual Meeting

May 11, 2018

Oncolytics Biotech® Reports 2018 First Quarter Results

May 10, 2018

Oncolytics Biotech® Receives Special Protocol Assessment Agreement from FDA for Phase 3 Clinical Trial of Pelareorep In Metastatic Breast Cancer

May 4, 2018

Oncolytics Biotech® Announces Voting Results from its Annual General Meeting of Shareholders

Apr 26, 2018

Oncolytics Biotech(R) Announces Details of 2018 Annual General Meeting of Shareholders

Apr 18, 2018

Oncolytics Biotech(R) Demonstrates Positive Data in Two Posters at AACR Annual Meeting 2018

Apr 17, 2018

Oncolytics Biotech(R) Announces Management Change

Apr 10, 2018

Oncolytics Biotech(R) Presents Positive REOLYSIN(R) Data in Combination with Keytruda and anti-CD73 at International Oncolytic Virus Conference 2018

Apr 4, 2018

Oncolytics Biotech(R) to Present at the MicroCap Conference

Mar 20, 2018

Oncolytics Biotech(R) Scientist Selected to Participate in the Society of Immunotherapy of Cancer's (SITC) METIOR Incubator Program